Loading...
Estimating the risk for late effects of therapy in children newly diagnosed with standard risk acute lymphoblastic leukemia using an historical cohort: A report from the Childhood Cancer Survivor Study
BACKGROUND: Pediatric acute lymphoblastic leukemia (ALL) therapy has evolved such that the risk for late effects in ALL survivors treated on contemporary protocols is likely different from that observed in survivors treated in prior eras. We estimated the risk for late effects in children with stand...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2014
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4142216/ https://ncbi.nlm.nih.gov/pubmed/24954778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)70265-7 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|